$2 billion Required to Support the Development of a Vaccine Against COVID-19

18 March 2020

GMP News

The Coalition for Epidemic Preparedness Innovations (CEPI), the organisation set up to accelerate the development of vaccines against emerging infectious diseases, has made an urgent call for $2 billion to support the development of a vaccine against the virus responsible for COVID-19.

The call for $2 billion of new funding will enable CEPI to expand the number of vaccine candidates at the outset to increase the chances of success, and to fund the clinical trials for these candidate vaccines. CEPI ambition is to have at least 3 vaccine candidates, which could be submitted to regulatory authorities for licensure for general use/use in outbreaks.

CEPI has identified five funding phases that will enable to start work now:

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more